Show simple item record

dc.contributor.advisorUscategui Ruiz, Adriana Catalina
dc.contributor.advisorCarreño Jaimes, Marisol
dc.contributor.authorGomez Boada, Diego Fernando
dc.contributor.authorParra Amaris, Camilo Andres
dc.coverage.spatialHospital Militar Central, Bogota, Colombiaspa
dc.coverage.temporal2017-2020spa
dc.date.accessioned2021-02-22T16:28:44Z
dc.date.available2021-02-22T16:28:44Z
dc.date.issued2021-01-28
dc.identifier.urihttp://hdl.handle.net/10654/37418
dc.description.abstractIntroducción: Las infecciones asociadas a catéter venoso central (IACVC) se encuentran dentro de las patologías que aumentan la mortalidad y morbilidad en pacientes hospitalizados con algún tipo de dispositivo, estando consideradas como parte los indicadores de gestión clínica. Objetivo: Describir las características de la infección asociada a catéter venoso central y los costos directos asociados a la misma en el Hospital Militar Central utilizando una herramienta de Health Anlytics en el periodo 2017 hasta el 2020. Metodología: Estudio de evaluación económica, estimación de costos directos relacionados con la infección asociada a CVC. Se utilizo la metodología de costos directos, por medio de la revisión de registros médicos electrónicos con estimación de costos de acuerdo con las recomendaciones del IETS. Análisis estadístico bivariado para identificar diferencias estadísticamente significativas Resultados: La población incluida para el análisis fue un total de 821 CVC entre 2017 y 2020. En relación con el análisis bivariado se identificaron diferencias estadísticamente significativas en el caso sexo, edad, frecuencia de comorbilidades, especialidad tratante, numero de vías del CVC, sitio de inserción, profesional a cargo de inserción, lugar del procedimiento, duración en días del CVC, tiempo de hospitalización, tiempo de estancia en hospitalización convencional, tiempo de estancia en Unidad de Cuidado Intensivo, uso de Ventilacion Mecanica Invasiva, uso de Ventilacion Mecanica No Invasiva, uso de Nutricion Parenteral Total, uso de Antibiotico, uso de Terapia de reemplazo renal. Para el análisis de costos directos a nivel hospitalario se identificó un costo total en lo pacientes sin diagnóstico de infección CVC fue de $31.822.751 COP (RIC $16.772.009-69.038.536 COP). Se identificó una diferencia estadísticamente significativa entre los pacientes con infección asociada al CVC comparado con aquellos pacientes sin infección para los casos de costos asociados a hospitalización (p=0,013), a procedimientos (p=0,0002), a imágenes diagnosticas (p=0,061), a terapia de reemplazo renal (p=0,0003) y costos totales (p=0,028). Conclusiones El presente estudio permite confirmar hallazgos previamente descritos en nuestra institución de una frecuencia similar de IACVC al compararse con reportes nacionales y mayor en comparación con lo repostado por literatura anglosajona, así mismo permite confirmar el incremento de los costos directos asociados a la presencia de IACVC, en donde se evidencia un incremento en los costos asociados a hospitalización, a procedimientos, a imágenes diagnosticas, a terapia de reemplazo renal y costos totales de forma estadísticamente significativa.spa
dc.description.tableofcontents1. RESUMEN 4 2. INTRODUCCIÓN 7 3. MARCO TEÓRICO 9 4. IDENTIFICACIÓN Y FORMULACIÓN DEL PROBLEMA 19 4.1. PREGUNTA DE INVESTIGACIÓN 20 5. OBJETIVOS E HIPÓTESIS 21 5.1. GENERAL 21 5.2. ESPECÍFICOS 21 6. METODOLOGÍA 22 6.1 Tipo y diseño general del estudio 22 6.2 Lugar de la investigación 22 6.3 Población 22 6.3.1. Población Blanco 22 6.3.2. Población Referencia 22 6.3.3. Población estudio 22 6.4 Criterios de inclusión y exclusión 22 6.4.1 Criterios de inclusión 22 6.4.2 Criterios de exclusión 23 6.5 Selección y tamaño de muestra 23 6.5.1. Muestreo 23 6.5.2. Tamaño de la muestra 23 6.6 Definición de las variables 24 6.7. Estudios de intervención 26 6.8. Estrategias para suprimir amenazas a la validez de resultados 26 6.9. Plan de recolección de datos 27 6.10. Plan de análisis 27 7. ASPECTOS ÉTICOS 29 8. RESULTADOS 30 9. DISCUSIÓN 38 10. CONCLUSIONES 43 11. REFERENCIAS BIBLIOGRÁFICAS 44spa
dc.format.mimetypeapplicaction/pdfspa
dc.language.isospaspa
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.titleAnálisis y costo de infección asociada a catéter venoso central en el Hospital Militar Central con utilización de herramienta de Health Analyticsspa
dc.rights.accessrightsinfo:eu-repo/semantics/openAccessspa
dc.rights.accessrightshttp://purl.org/coar/access_right/c_abf2*
dc.type.localTesis/Trabajo de grado - Monografía - Especializaciónspa
dc.description.abstractenglishIntroduction: Central venous catheter-associated infections (CVCAI) are among the pathologies that increase mortality and morbidity in patients hospitalized with some type of device, being considered as part of the clinical management indicators. Objective: To describe characteristics of CVCAI and the direct costs associated with them in the Central Military Hospital using a Health Analysis tool in the period 2017 to 2020. Methodology: Economic evaluation study, estimation of direct costs related to CVCAI. The direct costs methodology was used, through the review of electronic medical records with cost estimates in accordance with the IETS recommendations. Bivariate statistical analysis was used to identify statistically significant differences. Results: The population included for the analysis was a total of 821 CVC between 2017 and 2020. Statistically significant differences were identified for sex, age, comorbidities, treating specialty, number of CVC routes, site of insertion, professional in charge of insertion, place of the procedure, duration of CVC, hospitalization length, use of Invasive Mechanical Ventilation, use of Non Invasive Mechanical Ventilation, use of Total Parenteral Nutrition, use of Antibiotics, use of renal replacement therapy. For the analysis of direct costs at the hospital level, a total cost in patients without a diagnosis of CVC infection was identified as $ 31,822,751 COP (IQR $ 16,772,009-69,038,536 COP). A statistically significant difference was identified between patients with CVCAI compared to patients without infection for cases of costs associated with hospitalization (p = 0.013), procedures (p = 0.0002), diagnostic images (p = 0.061), renal replacement therapy (p = 0.0003), and total costs (p = 0.028). Conclusions The present study allows us to confirm findings previously described in our institution of a similar frequency of CVCIA when compared with national reports and higher compared to that reported by Anglo-Saxon literature, likewise it allows confirming the increase in direct costs associated with the presence of CVCIA, where an increase in costs associated with hospitalization, procedures, diagnostic images, renal replacement therapy and total costs is evidenced in a statistically significant way.spa
dc.title.translatedAnalysis and cost of infection associated with a central venous catheter in the Central Military Hospital using the Health Analytics toolspa
dc.subject.keywordsCentral venous catheter-associated infectionspa
dc.subject.keywordsDirect costsspa
dc.subject.keywordsCatheter-associated bacteraemiaspa
dc.subject.keywordsHealth related infectionspa
dc.publisher.programMedicina Internaspa
dc.creator.degreenameEspecialista en Medicina Internaspa
dc.subject.decsCateterismo Venoso Centralspa
dc.subject.decsInfecciones Relacionadas con Catéteresspa
dc.subject.decsInfección Hospitalariaspa
dc.subject.decsControl de Infeccionesspa
dc.description.degreelevelEspecializaciónspa
dc.publisher.facultyFacultad de Medicinaspa
dc.type.driverinfo:eu-repo/semantics/bachelorThesisspa
dc.rights.creativecommonsAttribution-NonCommercial-NoDerivatives 4.0 Internationalspa
dc.relation.referencesHajjej Z, Nasri M, Sellami W, Gharsallah H, Labben I, Ferjani M. Incidence, risk factors and microbiology of central vascular catheterrelated bloodstream infection in an intensive care unit. J Infect Chemother. 2014;20(3):163–8.spa
dc.relation.referencesEsposito S, Purrello SM, Bonnet E, Novelli A, Tripodi F, Pascale R, et al. Central venous catheter-related biofilm infections: An up-to-date focus on meticillin-resistant Staphylococcus aureus. J Glob Antimicrob Resist. 2013;1(2):71–8spa
dc.relation.referencesKandilov A, Coomer N, Dalton K. The Impact of Hospital-Acquired Conditions on Medicare Program Payments. Medicare Medicaid Res Rev. 2014;4(4):E1–23.spa
dc.relation.referencesHerzer KR, Niessen L, Constenla DO, Ward WJ, Pronovost PJ. Cost-effectiveness of a quality improvement programme to reduce central line-associated bloodstream infections in intensive care units in the USA. BMJ Open. 2014;4(9).spa
dc.relation.referencesMoreno CA, Rosenthal VD, Olarte N, Gomez WV, Sussmann O, Agudelo JG, et al. Device-associated infection rate and mortality in intensive care units of 9 Colombian hospitals: findings of the International Nosocomial Infection Control Consortium. Infect Control Hosp Epidemiol. 2006 Apr;27(4):349–56.spa
dc.relation.referencesZingg W, Sax H, Inan C, Cartier V, Diby M, Clergue F, et al. Hospital-wide surveillance of catheter-related bloodstream infection: from the expected to the unexpected. J Hosp Infect. 2009;73(1):41–6.spa
dc.relation.referencesRodríguez-Baño J, López-Prieto MD, Portillo MM, Retamar P, Natera C, Nuño E, et al. Epidemiology and clinical features of community-acquired, healthcare-associated and nosocomial bloodstream infections in tertiary-care and community hospitals. Clin Microbiol Infect. 2010 Sep;16(9):1408–13.spa
dc.relation.referencesRichet H, Hubert B, Nitemberg G, Andremont A, Buu-Hoi A, Ourbak P, et al. Prospective multicenter study of vascular-catheter-related complications and risk factors for positive central-catheter cultures in intensive care unit patients. J Clin Microbiol. 1990;28(11):2520–5.spa
dc.relation.referencesGoetz AM, Wagener MM, Miller JM, Muder RR. Risk of infection due to central venous catheters: effect of site of placement and catheter type. Infect Control Hosp Epidemiol. 1998;19(11):842–5.spa
dc.relation.referencesRuesch S, Walder B, Tramèr MR. Complications of central venous catheters: Internal jugular versus subclavian access - A systematic review. Crit Care Med. 2002;30(2):454–60.spa
dc.relation.referencesM.T. O, D.F. K, M.B. E. Use of ethanol lock therapy to reduce the incidence of catheter-related bloodstream infections in home parenteral nutrition patients. J Parenter Enter Nutr. 2007;31(4):302–5.spa
dc.relation.referencesZürcher M, Tramèr MR, Walder B. Colonization and bloodstream infection with single- versus multi-lumen central venous catheters: A quantitative systematic review. Anesth Analg. 2004;99(1):177–82.spa
dc.relation.referencesChen HS, Wang FD, Lin M, Lin YC, Huang LJ, Liu CY. Risk factors for central venous catheter-related infections in general surgery. J Microbiol Immunol Infect. 2006;39(3):231–6.spa
dc.relation.referencesMermel LA, Allon M, Bouza E, Craven DE, Flynn P, O’Grady NP, et al. Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 Update by the Infectious Diseases Society of America. Clin Infect Dis. 2009 Jul 1;49(1):1–45.spa
dc.relation.referencesZingg W, Cartier-Fässler V, Walder B. Central venous catheter-associated infections. Best Pract Res Clin Anaesthesiol. 2008;22(3):407–21.spa
dc.relation.referencesWebster J, Osborne S, Rickard C, Hall J. Clinically-indicated replacement versus routine replacement of peripheral venous catheters (Review). Chochrane Libr. 2010;(3):1–29.spa
dc.relation.referencesWebster J, Osborne S, Rickard CM, Marsh N. Clinically-indicated replacement versus routine replacement of peripheral venous catheters. Cochrane database Syst Rev. 2019;1:CD007798.spa
dc.relation.referencesTacconelli E, Smith G, Hieke K, Lafuma A, Bastide P. Epidemiology, medical outcomes and costs of catheter-related bloodstream infections in intensive care units of four European countries: literature- and registry-based estimates. J Hosp Infect. 2009;72(2):97–103.spa
dc.relation.referencesPeng S, Lu Y. Clinical epidemiology of central venous catheter-related bloodstream infections in an intensive care unit in China. J Crit Care. 2013;28(3):277–83.spa
dc.relation.referencesRichards MJ, Edwards JR, Culver DH, Gaynes RP. Nosocomial Infections in Pediatric Intensive Care Units in the United States. Pediatrics. 2004;103(4):e39–e39.spa
dc.relation.referencesMehta A, Rosenthal VD, Mehta Y, Chakravarthy M, Todi SK, Sen N, et al. Device-associated nosocomial infection rates in intensive care units of seven Indian cities. Findings of the International Nosocomial Infection Control Consortium (INICC). J Hosp Infect. 2007;67(2):168–74.spa
dc.relation.referencesRamirez Barba EJ, Rosenthal VD, Higuera F, Oropeza MS, Hernández HT, López MS, et al. Device-associated nosocomial infection rates in intensive care units in four Mexican public hospitals. Am J Infect Control. 2006;34(4):244–7.spa
dc.relation.referencesRosenthal VD, Guzmán S, Crnich C. Device-Associated Nosocomial Infection Rates in Intensive Care Units of Argentina. Infect Control Hosp Epidemiol. 2004 Mar 2;25(3):251–5.spa
dc.relation.referencesÁvila Guzmán, Miriam Lucia Moreno Peralta, Colombia Torres Pinzón H. Factores de riesgo asociados a infección por catéter venoso central en pacientes hospitalizados mayores de 18 años en el Hospital Militar Central de Bogotá Colombia entre enero y abril de 2008spa
dc.relation.referencesulido Daza SL, Cardona Vargas F, Jaramillo L, Rodrigo Bastidas A. Incidencia de la bacteriemia asociada a catéter venoso central y prevalencia de los diferentes factores de riesgo para la misma en el hospital militar central (homic) entre el año 2013 al 2015. 2016.spa
dc.relation.referencesWarren DK, Quadir WW, Hollenbeak CS, Elward AM, Cox MJ, Fraser VJ. Attributable cost of catheter-associated bloodstream infections among intensive care patients in a nonteaching hospital. Crit Care Med. 2006;34(8):2084–9spa
dc.relation.referencesDimick JB, Pelz RK, Consunji R, Swoboda SM, Hendrix CW, Lipsett PA. Increased resource use associated with catheter-related bloodstream infection in the surgical intensive care unit. Arch Surg. 2001;136(2):229–34spa
dc.relation.referencesRosa E, Borba A. Infección De Corriente Sanguínea En Pacientes Con Catéter Venosos Bloodstream Infections Among Patients Using Central Venous. Online. 2007;15(3).spa
dc.relation.referencesBrunelli SM, Turenne W, Sibbel S, Hunt A, Pfaffle A. Clinical and economic burden of bloodstream infections in critical care patients with central venous catheters. J Crit Care. 2016;35:69–74.spa
dc.relation.referencesBlot SI, Depuydt P, Annemans L, Benoit D, Hoste E, De Waele JJ, et al. Clinical and Economic Outcomes in Critically Ill Patients with Nosocomial Catheter-Related Bloodstream Infections. Clin Infect Dis. 2005;41(11):1591–8.spa
dc.relation.referencesRenaud B, Brun-Buisson C. Outcomes of primary and catheter-related bacteremia: A cohort and case-control study in critically III patients. Am J Respir Crit Care Med. 2001;163(7):1584–90.spa
dc.relation.referencesLeistner R, Hirsemann E, Bloch A, Gastmeier P, Geffers C. Costs and prolonged length of stay of central venous catheter-associated bloodstream infections (CVC BSI): A matched prospective cohort study. Infection. 2014;42(1):31–6.spa
dc.relation.referencesGuembe M, Pérez-Granda MJ, Capdevila JA, Barberán J, Pinilla B, Martín-Rabadán P, et al. Nationwide study on peripheral-venous-catheter-associated-bloodstream infections in internal medicine departments. J Hosp Infect. 2017;97(3):260–6.spa
dc.relation.referencesCai Y, Zhu M, Sun W, Cao X, Wu H. Study on the cost attributable to central venous catheter-related bloodstream infection and its influencing factors in a tertiary hospital in China. Health Qual Life Outcomes. 2018;16(1):2–7.spa
dc.relation.referencesNakamura I, Fukushima S, Hayakawa T, Sekiya K, Matsumoto T. The additional costs of catheter-related bloodstream infections in intensive care units. Am J Infect Control. 2015;43(10):1046–9.spa
dc.relation.referencesdel Pozo JL, Serrera A, Martínez-Cuesta A, Leiva J, Penadés J, Lasa I. Biofilm related infections: Is there a place for conservative treatment of port-related bloodstream infections? Int J Artif Organs. 2006;29(4):379–86spa
dc.relation.referencesStevens V, Geiger K, Concannon C, Nelson RE, Brown J, Dumyati G. Inpatient costs, mortality and 30-day re-admission in patients with central-line-associated bloodstream infections. Clin Microbiol Infect. 2014;20(5):O318–24.spa
dc.relation.referencesHsu E, Lin D, Evans SJ, Hamid KS, Frick KD, Yang T, et al. Doing Well by Doing Good: Assessing the Cost Savings of an Intervention to Reduce Central Line–Associated Bloodstream Infections in a Hawaii Hospital. Am J Med Qual. 2014;29(1):13–9.spa
dc.relation.referencesVoor in ‘t holt AF, Helder OK, Vos MC, Schafthuizen L, Sülz S, van den Hoogen A, et al. Antiseptic barrier cap effective in reducing central line-associated bloodstream infections: A systematic review and meta-analysis. Int J Nurs Stud. 2017;69:34–40.spa
dc.relation.referencesCooper K, Frampton G, Harris P, Jones J, Cooper T, Graves N, et al. Are educational interventions to prevent catheter-related bloodstream infections in intensive care unit cost-effective? J Hosp Infect. 2014;86(1):47–52.spa
dc.relation.referencesShimoyama Y, Umegaki O, Agui T, Kadono N, Komasawa N, Minami T. An educational program for decreasing catheter-related bloodstream infections in intensive care units: a pre- and post-intervention observational study. JA Clin Reports. 2017;3(1):2–7.spa
dc.relation.referencesMusu M, Finco G, Mura P, Landoni G, Piazza MF, Messina M, et al. Controlling catheter-related bloodstream infections through a multi-centre educational programme for intensive care units. J Hosp Infect. 2017;97(3):275–81spa
dc.relation.referencesCohen ER, Feinglass J, Barsuk JH, Barnard C, O’Donnell A, McGaghie WC, et al. Cost savings from reduced catheter-related bloodstream infection after simulation-based education for residents in a medical intensive care unit. Simul Healthc. 2010;5(2):98–102spa
dc.relation.referencesNelson RE, Angelovic AW, Nelson SD, Gleed JR, Drews FA. An Economic Analysis of Adherence Engineering to Improve Use of Best Practices during Central Line Maintenance Procedures. Infect Control Hosp Epidemiol. 2015;36(5):550–6.spa
dc.relation.referencesHalton KA, Cook D, Paterson DL, Safdar N, Graves N. Cost-effectiveness of a central venous catheter care bundle. PLoS One. 2010;5(9):1–11.spa
dc.relation.referencesCicalini S, Palmieri F, Petrosillo N. Clinical review: New technologies for prevention of intravascular catheter-related infections. Crit Care. 2004;8(3):157–62spa
dc.relation.referencesNuckols TK, Keeler E, Morton SC, Anderson L, Doyle B, Booth M, et al. Economic evaluation of quality improvement interventions for bloodstream infections related to central catheters: A systematic review. JAMA Intern Med. 2016;176(12):1843–54.spa
dc.relation.referencesO’Horo JC, Silva GLM, Safdar N. Anti-infective locks for treatment of central line-associated bloodstream infection: A systematic review and meta-analysis. Am J Nephrol. 2011;34(5):415–22.spa
dc.relation.referencesCivetta JM, Hudson-Civetta J, Ball S. Decreasing catheter-related infection and hospital costs by continuous quality improvement. Vol. 24, Critical Care Medicine. 1996. p. 1660–5.spa
dc.relation.referencesVeenstra DL, Saint S, Sullivan SD. Central Venous Catheters for the Prevention of Catheter-Related Bloodstream Infection. JAMA. 1999;282:554–60spa
dc.relation.referencesHeimann SM, Biehl LM, Vehreschild JJ, Franke B, Cornely OA, Vehreschild MJGT. Chlorhexidine-containing dressings in the prevention of central venous catheter-related bloodstream infections: A cost and resource utilization analysis. Am J Infect Control. 2018;46(9):992–7spa
dc.relation.referencesLorente L, Lecuona M, Jiménez A, Santacreu R, Raja L, Gonzalez O, et al. Chlorhexidine-silver sulfadiazine-impregnated venous catheters save costs. Am J Infect Control. 2014;42(3):321–4.spa
dc.relation.referencesLorente L, Lecuona M, Ramos MJ, Jiménez A, Mora ML, Sierra A. Lower associated costs using rifampicin-miconazoleimpregnated catheters compared with standard catheters. Am J Infect Control. 2011;39(10):895–7spa
dc.relation.referencesLorente L. Antimicrobial-impregnated catheters for the prevention of catheter-related bloodstream infections. World J Crit Care Med. 2016;5(2):137spa
dc.relation.referencesHalton KA, Cook DA, Whitby M, Paterson DL, Graves N. Cost effectiveness of antimicrobial catheters in the intensive care unit: Addressing uncertainty in the decision. Crit Care. 2009;13(2):1–10.spa
dc.relation.referencesCrawford AG, Fuhr JP, Rao B. Cost-benefit analysis of chlorhexidine gluconate dressing in the prevention of catheter-related bloodstream infections. Infect Control Hosp Epidemiol. 2004 Aug;25(8):668–74spa
dc.relation.referencesSchwebel C, Lucet JC, Vesin A, Arrault X, Calvino-Gunther S, Bouadma L, et al. Economic evaluation of chlorhexidine-impregnated sponges for preventing catheter-related infections in critically ill adults in the Dressing Study. Crit Care Med. 2012;40(1):11–7spa
dc.relation.referencesMaenthaisong R, Chaiyakunapruk N, Thamlikitkul V. Cost-effectiveness analysis of chlorhexidine gluconate compared with povidone-iodine solution for catheter-site care in Siriraj Hospital, Thailand. J Med Assoc Thail. 2006;89(SUPPL. 5):94–101.spa
dc.relation.referencesFraher MH, Collins CJ, Bourke J, Phelan D, Lynch M. Cost-effectiveness of employing a total parenteral nutrition surveillance nurse for the prevention of catheter-related bloodstream infections. J Hosp Infect. 2009;73(2):129–34.spa
dc.relation.referencesNational Nosocomial Infections Surveillance System. National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004. Am J Infect Control. 2004 Dec;32(8):470–85spa
dc.subject.proposalInfección asociada a catéter venoso centralspa
dc.subject.proposalCostos directosspa
dc.subject.proposalBacteriemia asociada a catéterspa
dc.subject.proposalInfección relacionada con el cuidado de la saludspa
dc.publisher.grantorUniversidad Militar Nueva Granadaspa
dc.type.coarhttp://purl.org/coar/resource_type/c_7a1f*
dc.type.hasversioninfo:eu-repo/semantics/acceptedVersionspa
dc.identifier.instnameinstname:Universidad Militar Nueva Granadaspa
dc.identifier.reponamereponame:Repositorio Institucional Universidad Militar Nueva Granadaspa
dc.identifier.repourlrepourl:https://repository.unimilitar.edu.cospa
dc.rights.localAcceso abiertospa
dc.coverage.sedeMedicinaspa


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record

http://creativecommons.org/licenses/by-nc-nd/4.0/
Except where otherwise noted, this item's license is described as http://creativecommons.org/licenses/by-nc-nd/4.0/